|Day Low/High||2.77 / 2.97|
|52 Wk Low/High||1.04 / 3.45|
TheStreet highlights 3 stocks pushing the Conglomerates sector lower today.
Shares of Lipocine (LPCN) soared in morning trading Wednesday after the pharmaceutical company announced positive results from its Phase 3 trial of its oral treatment LPCN 1021 for low testosterone.
Conference Call and Webcast Scheduled for 8:45 a.m. Eastern Time Tomorrow
The biotech sector hews close to an academic calendar and September marks the start of the busy, event-filled push into the end of the year.
Lipocine Inc. (“Lipocine”) ( OTCQB/OTCBB: LPCN), a specialty pharmaceutical company, announced today that Morgan Brown has joined the Company as Executive Vice President and Chief Financial Officer...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.